Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Childhood

View All Childhood HepB Birth Dose Pregnancy
Adolescents Combination Vaccines HIV Registries
Adoption Dialysis Long-Term Care Schedules
Adults General Recommendations Men + Men Travel
Biopreparedness Healthcare Personnel Postexposure Prophylaxis
 

Recommendations - Childhood

Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
Source: MMWR, June 20, 2014; 63(24):527-530
HTML  |  PDF
Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Recommendations and Reports
Source: MMWR, February 28, 2014; 63(RR01):1-14
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013; 62(25):521-524
HTML  |  PDF
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
Source: MMWR, January 25, 2013; 62(3):52-4
HTML  |  PDF
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years - United States, 2012
Source: MMWR, February 10, 2012; 61(5):1-4
HTML  |  PDF
 
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2
HTML  |  PDF
 
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
 
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
 
Prevention of Pneumococcal Disease Among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
Source: MMWR, December 10, 2010; 59(RR11):1-18
HTML  |  PDF
 
Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11
Source: MMWR, August 13, 2010; 59(31):989-92
HTML  |  PDF
 
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16
HTML  |  PDF
 
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):258-261
HTML  |  PDF
 
Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine
Source: MMWR September 18, 2009; 58(36):1008-1009
HTML  |  PDF
 
Use of Influenza A (H1N1) 2009 Monovalent Vaccine
Source: MMWR, August 28, 2009; 58(RR10):1-8
HTML  |  PDF
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Routine Poliovirus Vaccination
Source: MMWR, August 7, 2009; 58(30):829-30
HTML  |  PDF
Prevention of Rotavirus Gastroenteritis Among Infants and Children: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, February 6, 2009, Vol. 58 (RR-2)
HTML  |  PDF
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344
HTML  |  PDF
Notice to Readers: Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, December 7, 2007; 56(48):1265-1266
HTML  |  PDF
Expansion of Use of Live Attenuated Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other FluMist Changes for the 2007--08 Influenza Season
Source: MMWR, November 23, 2007; 56(46):1217-1219
HTML  |  PDF
Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795
HTML  |  PDF
Prevention of Varicella
Source: MMWR, June 22, 2007; 56(RR-4):1-40
HTML  |  PDF
Quadrivalent Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24
HTML  |  PDF
Control and Elimination of Mumps
Source: MMWR, June 9, 2006, Vol. 55(22):629-630
HTML  |  PDF
Prevention and Control of Meningococcal Disease
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21
HTML  |  PDF
Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB)
HTML  |  PDF
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13
HTML  |  PDF
Preventing Pneumococcal Disease Among Infants and Young Children
Source: MMWR October 6, 2000 / Vol. 49 / No. RR-09
HTML  |  PDF
Prevention and Control of Meningococcal Disease
Source:MMWR June 30, 2000 / Vol. 49 / No. RR-07
HTML  |  PDF
Poliomyelitis Prevention in the United States
Source: MMWR May 19, 2000 / Vol. 49 / No. RR-05
HTML  |  PDF
Use of Haemophilus b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13
HTML  |  PDF
Diphtheria, Tetanus, and Pertussis, Recommendations for Vaccine Use and Other Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10
HTML  |  PDF
Haemophilus b Conjugate Vaccines for Prevention of Hib Disease
Source: MMWR January 11, 1991 / Vol. 40 / No. RR-01
HTML  |  PDF
This page was reviewed on June 20, 2014
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.